Financial statements Direct Pharma

Balance sheet of Direct Pharma

Company age:
Age:
9 y. 10 m. 3 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of DIRECT PHARMA

Year
2017
2018
2019
2020
2021
2022
2023
Total assets 1 053 016,43 334 581,69 843 139,31 1 788 749,55 2 094 667,59 572 316,69 654 097,14
A. Fixed assets 204 367,64 268 245,51 116 320,58 77 547,05 38 773,52 16 155,63 16 155,63
B. Current assets 848 648,79 66 336,18 726 818,73 1 711 202,50 2 055 894,07 556 161,06 637 941,51
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 - 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 - 0,00 0,00
Total liabilities 1 053 016,43 334 581,69 843 139,31 1 788 749,55 2 094 667,59 572 316,69 654 097,14
A. Equity 21 824,23 -6 745,96 -788 988,51 -616 593,03 -960 733,36 -1 363 655,79 -1 521 031,95
B. Liabilities and provisions for liabilities 1 031 192,20 341 327,65 1 631 916,51 2 405 342,58 3 055 400,95 1 935 972,48 2 175 129,09
I. Long-term liabilities - - - - - - -
II. Short-term liabilities - - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.